Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer Head of R&D Business Development-Asia Alex Fowkes On Developing R&D Strategies For Asia: An Interview With PharmAsia News (Part 1 of 2)

This article was originally published in PharmAsia News

Executive Summary

Pfizer Head of R&D Business Development-Asia Alex Fowkes sat down recently with PharmAsia News' Australia bureau to discuss Pfizer's research and business development strategies in Asia. Fowkes recently addressed a panel at the BioAsia conference in Singapore and discussed Pfizer's virtual networking approach to doing business in Asia, which offers more flexibility and creative approaches (PharmAsia News, May 8, 2008).
Advertisement

Related Content

Pfizer Forges New Research Partnership In China Aimed In Part At Fighting A Leading Cause Of Death
Pfizer Forges New Research Partnership In China Aimed In Part At Fighting A Leading Cause Of Death
Pfizer Forges Research Partnership In China Aimed At Fighting Cancers Prevalent In Asia
Pfizer Forges Research Partnership In China Aimed At Fighting Cancers Prevalent In Asia
Pfizer, Astellas Execs Talk Deals At BIO Asia
Bayer Looks To Singapore To Develop Cancer Drugs For Asian Patients
Pfizer Head of R&D Business Development – Asia Alex Fowkes On Matching Global Partners With Pfizer’s Pipeline: An Interview With PharmAsia News (Part 2 of 2)
A Tale Of Two Giants; Tracking India And China’s Rise In The Pharmaceutical Market
Big Pharma Stretches To Reshape Itself To Enter Asia With Flexible, Multiple-Partner Networks – Singapore Conference
Big Pharma Stretches To Reshape Itself To Enter Asia With Flexible, Multiple-Partner Networks – Singapore Conference
Advertisement
UsernamePublicRestriction

Register

SC069136

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel